About us

Our mission

PharmaBlue aims to contribute to a world where patients with unmet medical needs have better access to a variety of safe, effective healthcare products, and innovative treatments.

Who are we

PharmaBlue is a Partner for Innovative Pharmaceutical Companies

We are your Medium/Long term partner to get and run your Early Access Program in France.

We provide Exploitant services to our clients for rapidly marketing their approved medicines in France (orphan or unmet medical need).

Our Story

2015: PharmaBlue is founded in Sophia-Antipolis (south of France) to complement BlueReg Group offerered services. PharmaBlue is a “Laboratoire Exploitant” (authorized by the ANSM) enabling innovative pharmaceutical companies to market early access medicines under ATU. 

2017: PharmaBlue pharmaceutical site is moved to Paris to facilitate international exchanges.

2020: PharmaBlue’s Exploitant Establishment licensed is inspected by ANSM French National Agency for the Safety of Medicines and Health Products and successfully meet all the requirements.

2021: PharmaBlue is acquired by PharmaLex. In France, there is a major regulation change for Early Access, well handled by PharmaBlue that has obtained its first Authorization under the new regulation.

2022: PharmaBlue pursue its growth with the creation of two dedicated departments : Scientific Affairs and Quality.

2023:  PharmaLex group from which PharmaBlue belongs to is now part of Cencora, a leading global pharmaceutical solutions organization centered on improving lives..

2024: Valerie Colin PharmD, is appointed Head of PharmaBlue.

Plan de travail 97 copie 12@2x

Today PharmaBlue has more than 24 employees.

Our consultants are highly qualified with practical experience in the pharmaceutical industry. To date, PharmaBlue supports its clients based in Europe and in the United States through more than 58 projects to obtain Early Access Programs.

Why work with us

  • Exploitant Status : Immediate activation of French Affiliate – Exploitant Status
  • Access to Rare Skills & Experienced Early Access Team in France
  • Peace of mind operations on the French market

 

Our Assets

PharmaBlue is an established operating pharmaceutical company in France with “Exploitant” status.

PharmaBlue holds a robust quality management system and is authorized by the French Medicines Agency (ANSM).

Our team is composed of registered pharmacists or specialists, with significant experience in providing expert support to clients. 

 

What we offer

PharmaBlue provides “Exploitant” services to Pharmaceutical companies looking for a partner to launch their drugs on the French market. 

We have a significant experience in supporting clients to obtain early access programs in France (EAP previously called ATU).

We carry the responsibilities related to the distribution of pharmaceutical products in France (products with early access or marketing authorization – MA).

Plan de travail 97 copie 11@2x

Our Directors board

  • Valérie Colin

    Senior Director Head Of PharmaBlue

  • Marie Regnat-Sauvageon

    Director Quality Chief Pharmaceutical Officer

  • Amandine Gras

    Director Project Manager